Pituitary Adenylate Cyclase Activating Peptide (1-38) and its analog (Acetyl-[Ala15, Ala20] PACAP 38-polyamide) reverse methacholine airway hyperresponsiveness in rats

Bibliographic Details
Title: Pituitary Adenylate Cyclase Activating Peptide (1-38) and its analog (Acetyl-[Ala15, Ala20] PACAP 38-polyamide) reverse methacholine airway hyperresponsiveness in rats
Authors: Tlili, Mounira, Rouatbi, Sonia, Gandia, Fedoua, Hallegue, Dorsaf, Sriha, Badreddine, Yacoubi, Mohamed Taher, Krichah, Raja, Sakly, Mohsen, Rhouma, Khémais Ben, Vaudry, David, Wurtz, Olivier, Tebourbi, Olfa
Source: Brazilian Journal of Pharmaceutical Sciences. September 2015 51(3)
Publisher Information: Universidade de São Paulo, Faculdade de Ciências Farmacêuticas, 2015.
Publication Year: 2015
Subject Terms: Pituitary adenylate cyclase activating peptide/effects/inflammatory lung diseases, Pituitary adenylate cyclase/analogs/effects in inflammatory lung diseases, Methacholine, Bronchodilators/effects, Inflammatory lung diseases/treatment
More Details: The aim of this study was to investigate both functionally and structurally bronchodilator effects of Pituitary adenylate cyclase activating peptide (PACAP38) and acetyl-[Ala15, Ala20] PACAP38-polyamide, a potent PACAP38 analog, in rats challenged by methacholine (MeCh). Male Wistar rats were divided randomly into five groups. Groups 1 and 2 inhaled respectively aerosols of saline or increasing doses of MeCh (0.5, 1, 2.12, 4.25, 8.5, 17, 34 and 68mg/L). The other groups received terbutaline (Terb) (250 µg/rat) (10-6 M), PACAP38 (50 µg/rat) (0.1 mM) or PACAP38 analog (50 µg/rat) associated to MeCh from the dose of 4.25 mg/L. Total lung resistances (RL) were recorded before and 2 min after MeCh administration by pneumomultitest equipment. MeCh administration induced a significant and a dose-dependent increase (p<0.05) of RL compared to control rats. Terb, PACAP38 and PACAP38 analog reversed significantly the MeCh-induced bronchial constriction, smooth muscle (SM) layer thickness and bronchial lumen mucus abundance. PACAP38 analog prevents effectively bronchial smooth muscle layer thickness, mucus hypersecretion and lumen decrease. Therefore, it may constitute a potent therapeutic bronchodilator.
Document Type: article
File Description: text/html
Language: English
ISSN: 1984-8250
DOI: 10.1590/S1984-82502015000300020
Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502015000300681
Rights: info:eu-repo/semantics/openAccess
Accession Number: edssci.S1984.82502015000300681
Database: SciELO
More Details
ISSN:19848250
DOI:10.1590/S1984-82502015000300020
Published in:Brazilian Journal of Pharmaceutical Sciences
Language:English